ID
19908
Descripción
The purpose of this study is to determine the safety and efficacy of natalizumab in the treatment of individuals who have been diagnosed with relapsing remitting multiple sclerosis (MS). It is hoped that natalizumab will prevent certain types of white blood cells from moving out of the bloodstream into organs, including the brain, that are being damaged by autoimmune disease (a disease in which the body's own immune system attacks certain organs). These white blood cells are thought to cause inflammation that can result in lesions (small areas of damage) in the brain. These lesions are thought to be the cause of relapses and disability in MS. Documentation process: This form s to be obtained in (Dose 1) week 0 and (Dose 6) week 20.
Palabras clave
Versiones (1)
- 30/1/17 30/1/17 -
Subido en
30 de enero de 2017
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Intensive PK and PD CRFs Multiple Sclerosis Tysabri NCT00027300
Intensive PK and PD CRFs Multiple Sclerosis Tysabri NCT00027300
- StudyEvent: ODM
Descripción
Pharmacodynamics (alpha4 Integrin Saturation)
Alias
- UMLS CUI-1
- C0851347
Descripción
1. Pre-infusion
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0021440
- UMLS CUI [1,2]
- C0585032
Descripción
2. 2 hours +/- 15 minutes post-infusion
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0021440
- UMLS CUI [1,2]
- C3272301
- UMLS CUI [1,3]
- C4035164
Descripción
3. 1 week +/- 4 hours post-infusion
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0021440
- UMLS CUI [1,2]
- C3272301
- UMLS CUI [1,3]
- C1547085
Descripción
4. 2 weeks +/- 4 hours post-infusion
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0021440
- UMLS CUI [1,2]
- C3272301
- UMLS CUI [1,3]
- C0439230
Descripción
5. 3 weeks +/- 4 hours post-infusion
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0021440
- UMLS CUI [1,2]
- C3272301
- UMLS CUI [1,3]
- C0439230
Descripción
6. 4 weeks +/- 1 day post-infusion (prior to infusion dose #7)
Tipo de datos
integer
Alias
- UMLS CUI [1,1]
- C0021440
- UMLS CUI [1,2]
- C3272301
- UMLS CUI [1,3]
- C0439230
Similar models
Intensive PK and PD CRFs Multiple Sclerosis Tysabri NCT00027300
- StudyEvent: ODM
C3272301 (UMLS CUI [1,2])
C3272301 (UMLS CUI [1,2])
C4035164 (UMLS CUI [1,3])
C3272301 (UMLS CUI [1,2])
C1442770 (UMLS CUI [1,3])
C3272301 (UMLS CUI [1,2])
C1547085 (UMLS CUI [1,3])
C3272301 (UMLS CUI [1,2])
C0439230 (UMLS CUI [1,3])
C3272301 (UMLS CUI [1,2])
C0439230 (UMLS CUI [1,3])
C3272301 (UMLS CUI [1,2])
C0439230 (UMLS CUI [1,3])
C3272301 (UMLS CUI [1,2])
C4035164 (UMLS CUI [1,3])
C3272301 (UMLS CUI [1,2])
C1547085 (UMLS CUI [1,3])
C3272301 (UMLS CUI [1,2])
C0439230 (UMLS CUI [1,3])
C3272301 (UMLS CUI [1,2])
C0439230 (UMLS CUI [1,3])
C3272301 (UMLS CUI [1,2])
C0439230 (UMLS CUI [1,3])